These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25085375)

  • 1. Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease.
    Collin L; Bohrmann B; Göpfert U; Oroszlan-Szovik K; Ozmen L; Grüninger F
    Brain; 2014 Oct; 137(Pt 10):2834-46. PubMed ID: 25085375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice.
    Ittner A; Bertz J; Suh LS; Stevens CH; Götz J; Ittner LM
    J Neurochem; 2015 Jan; 132(1):135-45. PubMed ID: 25041093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice.
    Dai CL; Hu W; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2018 Jan; 10(1):13. PubMed ID: 29386065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
    Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau immunization: a cautionary tale?
    Mably AJ; Kanmert D; Mc Donald JM; Liu W; Caldarone BJ; Lemere CA; O'Nuallain B; Kosik KS; Walsh DM
    Neurobiol Aging; 2015 Mar; 36(3):1316-32. PubMed ID: 25619661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice.
    Rajamohamedsait H; Rasool S; Rajamohamedsait W; Lin Y; Sigurdsson EM
    Sci Rep; 2017 Dec; 7(1):17034. PubMed ID: 29213096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.
    Sankaranarayanan S; Barten DM; Vana L; Devidze N; Yang L; Cadelina G; Hoque N; DeCarr L; Keenan S; Lin A; Cao Y; Snyder B; Zhang B; Nitla M; Hirschfeld G; Barrezueta N; Polson C; Wes P; Rangan VS; Cacace A; Albright CF; Meredith J; Trojanowski JQ; Lee VM; Brunden KR; Ahlijanian M
    PLoS One; 2015; 10(5):e0125614. PubMed ID: 25933020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
    Sahara N; Vega IE; Ishizawa T; Lewis J; McGowan E; Hutton M; Dickson D; Yen SH
    J Neurochem; 2004 Aug; 90(4):829-38. PubMed ID: 15287888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice.
    Walls KC; Ager RR; Vasilevko V; Cheng D; Medeiros R; LaFerla FM
    Neurosci Lett; 2014 Jul; 575():96-100. PubMed ID: 24887583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
    Vana L; Kanaan NM; Ugwu IC; Wuu J; Mufson EJ; Binder LI
    Am J Pathol; 2011 Nov; 179(5):2533-50. PubMed ID: 21945902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J; Lauretti E; Craige CP; Praticò D
    J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics.
    Rosseels J; Van den Brande J; Violet M; Jacobs D; Grognet P; Lopez J; Huvent I; Caldara M; Swinnen E; Papegaey A; Caillierez R; Buée-Scherrer V; Engelborghs S; Lippens G; Colin M; Buée L; Galas MC; Vanmechelen E; Winderickx J
    J Biol Chem; 2015 Feb; 290(7):4059-74. PubMed ID: 25540200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.
    Davtyan H; Chen WW; Zagorski K; Davis J; Petrushina I; Kazarian K; Cribbs DH; Agadjanyan MG; Blurton-Jones M; Ghochikyan A
    Vaccine; 2017 Apr; 35(16):2015-2024. PubMed ID: 28320590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.
    Liu W; Zhao L; Blackman B; Parmar M; Wong MY; Woo T; Yu F; Chiuchiolo MJ; Sondhi D; Kaminsky SM; Crystal RG; Paul SM
    J Neurosci; 2016 Dec; 36(49):12425-12435. PubMed ID: 27927959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELISA measurement of specific antibodies to phosphorylated tau in intravenous immunoglobulin products.
    Loeffler DA; Klaver AC; Coffey MP
    Int Immunopharmacol; 2015 Oct; 28(2):1108-12. PubMed ID: 26330100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
    Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
    Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.